Description
AOD 9604 is a human growth hormone fragment profile investigated for lipolytic and metabolic effects, with evidence concentrated in preclinical and translational assay literature.
What it is
AOD 9604 is a synthetic hGH-fragment profile investigated for lipolysis and metabolism-related effects in preclinical and translational research.
Mechanism snapshot
- Derived from growth-hormone fragment biology linked to lipolytic signaling hypotheses.
- Investigated for lipid-metabolism and body-composition pathway effects in model systems.
- Studied in analytical metabolism work relevant to detection and translational characterization.
Research programs
- Metabolic-domain and lipolysis-focused preclinical studies.
- Obesity-model response evaluations in rodent systems.
- Analytical and anti-doping laboratory characterization studies.
Limitations
- Human efficacy data are limited and not definitive.
- Older datasets and heterogeneous endpoints constrain interpretation.
- Mechanistic lipolysis signals do not establish broad clinical benefit.
Selected references
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone - PubMed 2000
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice - PubMed 2001
- Detection and in vitro metabolism of AOD9604 - PubMed 2015
Ordering
Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.


